But it's also more expensive and can cause more side effects
Phase 2 trial results, published in 2023 in the New England Journal of Medicine (Jastreboff et al., NEJM 2023), demonstrated that participants receiving the highest dose of retatrutide lost an average of approximately 24% of their body weight over 48 weeks a finding that attracted considerable attention from the medical and scientific communities
Managing GLP-1 Side Effects Managing the side effects of GLP-1 medications is essential for maintaining long-term success in treatment
Visceral fat is metabolically active and releases inflammatory signals that influence insulin resistance and cardiovascular risk
Obesity and being overweight have become global health epidemics, with staggering statistics indicating that over 1 billion people worldwide are affected
Following in Medicare Part Ds footsteps, commercial insurers have traditionally covered GLP-1s only for Type 2 diabetes diagnoses, while largely denying coverage for weight loss